Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Pozycja w akcjach
#4949
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Cena akcji
$2.47
Kapitalizacja rynkowa
$2.95B
Zmiana (1 dzień)
0.18%
Zmiana (1 rok)
-14.53%
Kraj
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategoria
Healthcare
Wskaźnik P/B dla Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Wskaźnik P/B na dzień October 2026 TTM: 0.60
Według najnowszych raportów finansowych i ceny akcji Jilin Aodong Pharmaceutical Group Co., Ltd., obecny wskaźnik P/B (TTM) wynosi 0.60. Na koniec 2023 wynosił 0.63.
Historia wskaźnika P/B dla Jilin Aodong Pharmaceutical Group Co., Ltd. od 2000 do 2026
Wskaźnik P/B na koniec każdego roku
| Rok | Wskaźnik P/B | Zmień |
|---|---|---|
| 2026 (TTM) | 0.60 | -13.67% |
| 2024 | 0.70 | 11.71% |
| 2023 | 0.63 | -4.03% |
| 2022 | 0.65 | -22.83% |
| 2021 | 0.85 | 3.64% |
| 2020 | 0.82 | -5.45% |
| 2019 | 0.86 | 8.73% |
| 2018 | 0.79 | -38.62% |
| 2017 | 1.29 | -11.82% |
| 2016 | 1.47 | -7.84% |
| 2015 | 1.59 | -35.53% |
| 2014 | 2.47 | 63.97% |
| 2013 | 1.51 | -4.54% |
| 2012 | 1.58 | 1.57% |
| 2011 | 1.55 | -42.84% |
| 2010 | 2.72 | -39.78% |
| 2009 | 4.51 | 103.81% |
| 2008 | 2.21 | -73.01% |
| 2007 | 8.20 | 53.64% |
| 2006 | 5.34 | 362.58% |
| 2005 | 1.15 | -5.59% |
| 2004 | 1.22 | 8.05% |
| 2003 | 1.13 | -35.55% |
| 2002 | 1.76 | -6.22% |
| 2001 | 1.87 | -38.50% |
| 2000 | 3.04 | 0.00% |
Wskaźnik P/B dla podobnych firm lub konkurentów
| Firma | Wskaźnik P/B | Różnica wskaźnika P/B | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 734.19% |
IN
|
